Effects of Dietary Fiber Supplementation on Modulating Uremic Toxins and Inflammation in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Effects of Dietary Fiber Supplementation on Modulating Uremic Toxins and Inflammation in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Emerging evidence supports the beneficial effects of dietary fiber supplementation in alleviating gut dysbiosis, which leads to a reduction in uremic toxins and inflammatory markers in chronic kidney disease (CKD) patients. However, current evidence-based renal nutrition guidelines do not provide re...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wannasit Wathanavasin, Wisit Cheungpasitporn, Charat Thongprayoon, Tibor Fülöp
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Toxins
Subjects:	dietary fiber uremic toxins chronic kidney disease inflammation gut dysbiosis
Online Access:	https://www.mdpi.com/2072-6651/17/2/57
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Microbial-Derived Uremic Toxins: Role in the Pathogenesis of Comorbidities in Patients with Chronic Kidney Disease
by: M. O. Pyatchenkov, et al.
Published: (2023-09-01)

Comparison of uremic toxin removal between expanded hemodialysis and high volume online hemodiafiltrations in different modes
by: Jan Biedunkiewicz, et al.
Published: (2024-11-01)

A specifically designed multi-biotic reduces uremic toxin generation and improves kidney function
by: Alice Beau, et al.
Published: (2025-12-01)

Future of Uremic Toxin Management
by: Raymond Vanholder, et al.
Published: (2024-10-01)

Lacticaseibacillus rhamnosus attenuates uremic toxins in patients with nondialysis chronic kidney disease through the anti-inflammatory molecules
by: Asada Leelahavanichkul, et al.
Published: (2025-07-01)

Transport of the uremic toxin symmetric dimethylarginine (SDMA) by renal transport proteins
by: Lorenz A. Scherpinski, et al.
Published: (2025-06-01)

Critical appraisal of systematic reviews and meta-analyses: a step-by-step guide for nephrologists
by: Wisit Cheungpasitporn, et al.
Published: (2025-12-01)

Vascular inflammation in chronic kidney disease: the role of uremic toxins in macrophage activation
by: Prabhash Kumar Jha, et al.
Published: (2025-03-01)

The Gut–Kidney Axis in Chronic Kidney Diseases
by: Kenji Tsuji, et al.
Published: (2024-12-01)

Association between gut microbial diversity and technique failure in peritoneal dialysis patients
by: Shulan Guo, et al.
Published: (2023-12-01)

Gut Dysbiosis and Its Role in the Anemia of Chronic Kidney Disease
by: Elisabet Coll, et al.
Published: (2024-11-01)

Furosemide and Serum Protein-Bound Uremic Toxin Concentrations in Patients With CKD
by: Margaux Costes-Albrespic, et al.
Published: (2025-07-01)

Monocytes serve as Shiga toxin carriers during the development of hemolytic uremic syndrome
by: Xinlei Sun, et al.
Published: (2025-01-01)

The influence of uremic toxins on low bone turnover disease in chronic kidney disease
by: Giou-Teng Yiang, et al.
Published: (2024-01-01)

From Physicochemical Classification to Multidimensional Insights: A Comprehensive Review of Uremic Toxin Research
by: Mario Cozzolino, et al.
Published: (2025-06-01)

Hemodiafiltration with endogenous reinfusion for uremic toxin removal in patients undergoing maintenance hemodialysis: a pilot study
by: Renhua Lu, et al.
Published: (2024-12-01)

Development of a convenient and rapid screening zebrafish model to investigate lethal effects and immunocompromised states of uremic toxins
by: Pema Jo, et al.
Published: (2025-12-01)

Uremic toxins levels are associated with miR-223 in chronic kidney disease-associated anemia
by: Emma Brisot, et al.
Published: (2025-08-01)

INM004: Polyclonal Neutralizing Antibodies Against Shiga Toxin as a Treatment for Hemolytic Uremic Syndrome
by: Marta Rivas, et al.
Published: (2025-06-01)

Concentrations of uremic bacterial metabolites in patients with post-COVID-19 syndrome
by: Natascha Brigo, et al.
Published: (2025-05-01)

Protein-bound uremic toxin clearance as biomarker of kidney tubular function in diabetic kidney disease
by: Sabbir Ahmed, et al.
Published: (2025-07-01)

Microbiota Modulation to Improve estimated Glomerular Filtration Rate, Uremic Toxins, and Inflammatory Marker in Chronic Kidney Disease: Systematic Review and Meta-Analysis
by: Burhan Gunawan, et al.
Published: (2023-03-01)

Reduction in Renal Heme Oxygenase-1 Is Associated with an Aggravation of Kidney Injury in Shiga Toxin-Induced Murine Hemolytic-Uremic Syndrome
by: Antonio N. Mestekemper, et al.
Published: (2024-12-01)

Evaluating artificial intelligence bias in nephrology: the role of diversity, equity, and inclusion in AI-driven decision-making and ethical regulation
by: Suryanarayanan Balakrishnan, et al.
Published: (2025-05-01)

Toward an effective delivery system of a microbial sink of the uremic toxin, p-cresol; an in vitro study with Thauera aminoaromatica S2
by: Prakit Saingam, et al.
Published: (2025-05-01)

The frequency of detection of markers of Сytomegalovirus infection in children with recurrent respiratory diseases in patients with Shiga-toxin-associated hemolytic-uremic syndrome (STEC-HUS)
by: I. B. Repina, et al.
Published: (2021-04-01)

Uremic toxin receptor NR1H3 contributes to hyperlipidemia- and chronic kidney disease-accelerated vascular inflammation, which is partially suppressed by novel YBX2 anti-ROS pathway
by: Yifan Lu, et al.
Published: (2025-09-01)

Fluorinated Zirconium‐Based Metal‐Organic Frameworks as Novel Sorbents to Improve the Efficacy of Hemodialysis Treatment
by: Fátima Guerrero, et al.
Published: (2025-07-01)

Management of pediatric hemolytic uremic syndrome
by: Bora Gülhan, et al.
Published: (2024-02-01)

The Uremic Toxins Inorganic Phosphate, Indoxylsulphate, p-Cresylsulphate, and TMAO Induce the Generation of Sulphated Glycosaminoglycans in Aortic Tissue and Vascular Cells via pAKT Signaling: A Missing Link in the “Gut–Matrix Axis”
by: Christian Freise, et al.
Published: (2025-04-01)

Modulatory effects of Lactiplantibacillus plantarum MA2 and its postbiotic on the adenine-induced chronic kidney disease
by: Weitao Geng, et al.
Published: (2025-01-01)

Inhibition of O‐GlcNAcylation protects from Shiga toxin‐mediated cell injury and lethality in host
by: Kyung‐Soo Lee, et al.
Published: (2021-11-01)

The role of plant-based dietary compounds in gut microbiota modulation in inflammatory bowel disease
by: Francis Atim Akanyibah, et al.
Published: (2025-05-01)

Pruritus in Uremic Patients: Approaches to Alleviating a Common Symptom in Chronic Kidney Disease
by: Ștefania Cîrstea, et al.
Published: (2025-06-01)

Intestinal microbiota and inflammation in chronic kidney disease
by: T. V. Zueva, et al.
Published: (2021-06-01)

Temporal Changes in Blood Metabolome Among Patients on Hemodialysis
by: Vida Dehghan Niestanak, et al.
Published: (2025-06-01)

Modern Approaches to the Management of Children with Atypical Hemolytic Uremic Syndrome
by: Khadizha M. Emirova, et al.
Published: (2022-05-01)

Carboxypeptidase B1 in dialyzed chronic kidney disease patients
by: Matej Stančík, et al.
Published: (2025-02-01)

Clinical characteristics and outcomes of 10 uremics with calciphylaxis
by: Xiao Jia, et al.
Published: (2022-04-01)

Association of Phenylacetylglutamine and Cognitive Impairment in CKD
by: Hélène Levassort, et al.
Published: (2025-08-01)